- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Technology that can determine the concentration of nanomaterials in living tissue has been licensed by The University of Texas at Austin to Houston-based nanoTox Inc.
The technology comes from the laboratory of Dr. James Tunnell, an assistant professor in the Department of Biomedical Engineering in the Cockrell School of Engineering. Tunnell's lab focuses on developing minimally invasive optical technologies for the detection, diagnosis and treatment of disease, particularly for application to cancer screening and therapeutics.
Nanoparticles are pure chemical or molecular materials smaller than one-tenth of a micrometer that are increasingly being used in a variety of applications, including medical devices, medicines and cosmetics.
In developing safe and effective products, one concern is knowing what becomes of nanoparticles applied or administered to the body. For example, nanoparticles designed to concentrate in certain locations such as tumor tissue for diagnostic or therapeutic purposes must not accumulate in other healthy tissues where they might cause harm such as the brain, heart, liver or kidneys.
Tunnell's tool, which employs optical spectroscopy, provides a non-invasive way for companies who use nanoparticles in their products to tell whether those particles remain in tissue or have been flushed out.
"This uses an optical fiber that you just place in contact with the tissue and the light makes a measurement in a non-invasive way," Tunnell said.
The current method for measuring nanoparticles at diagnostic or therapeutic concentrations in tissue typically involves the administration of radioisotopes or invasive procedures requiring a biopsy followed by time-consuming and costly examination using specialized forms of electron microscopy, X-ray analysis or nuclear chemical analysis in some cases.
"Dr. Tunnell has created a very minimally invasive technique to detect nanoparticles in tissue relatively simply and economically," said Greg King, vice president and chief operating officer of nanoTox®.
As a detection tool, it "will answer a lot of questions that government agencies and consumers are asking about nanomaterials," Harry Bushong, the company's president, said.
The license grants nanoTox® exclusive worldwide rights to the technology which includes the development of medical diagnostic applications. The company also plans to further develop the technology for other uses such as the nanotechnology risk-assessment market.
Nanotox has laboratory and research operations in Austin.
The company's chief scientific officer, Dr. David Hobson, said that working with Tunnell and his laboratory staff should lead to the development of this promising technology into a valuable tool for medical and nanotechnology safety assessment applications.
Understanding the risks from exposure to nanomaterials helps to satisfy international product liability insurers that support the development of beneficial applications of nanotechnology.
The company's scientists consult with engineers, chemists and other nanomaterial developers to identify and either eliminate or reduce significant toxicity found in a nanomaterial, thereby improving the safety of nanomaterials for customers, employees and the environment.
For more information, please click here
Office of the Vice President for Research
Copyright © University of Texas at AustinIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Nanoscale view of energy storage January 16th, 2017
NUS researchers achieve major breakthrough in flexible electronics: New classes of printable electrically conducting polymer materials make better electrodes for plastic electronics and advanced semiconductor devices January 14th, 2017
Manchester scientists tie the tightest knot ever achieved January 13th, 2017
New active filaments mimic biology to transport nano-cargo: A new design for a fully biocompatible motility engine transports colloidal particles faster than diffusion with active filaments January 11th, 2017
Arrowhead Provides Response to New Minority Shareholder Announcement January 7th, 2017
Nanoscale view of energy storage January 16th, 2017
Leti to Tackle Tomorrow's Research Strategies with Stanford University’s SystemX Alliance: French R&D Center Is the First Research Institute to Join the Collaboration and Provides Bridges Between Academia and Industry, Leveraging Alliance’s Potential October 4th, 2016
Picosun patents ALD nanolaminate to prevent electronics from overheating September 28th, 2016
NIST Patents Single-Photon Detector for Potential Encryption and Sensing Apps September 16th, 2016
Investigating the impact of natural and manmade nanomaterials on living things: Center for Environmental Implications of Nanotechnology develops tools to assess current and future risk January 9th, 2017
SUN shares its latest achievements during the 3rd Annual Project Meeting November 1st, 2016
The Sustainable Nanotechnologies Project’s Final Events: Bringing Nano Environmental Health and Safety Assessment to the Wider Discussion on Risk Governance of Key Enabling Technologies November 1st, 2016